Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Broadcom
AVGO
|
+$67.3M |
| 2 |
Veralto
VLTO
|
+$60.2M |
| 3 |
Newmont
NEM
|
+$43.4M |
| 4 |
Vertiv
VRT
|
+$19.4M |
| 5 |
Webster Financial
WBS
|
+$17.3M |
Top Sells
| 1 |
Apple
AAPL
|
+$328M |
| 2 |
Microsoft
MSFT
|
+$244M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$237M |
| 4 |
VMW
VMware, Inc
VMW
|
+$130M |
| 5 |
NVIDIA
NVDA
|
+$109M |
Sector Composition
| 1 | Technology | 30.91% |
| 2 | Healthcare | 12.91% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Industrials | 9.36% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
NET Power
NPWR
$164M
| $275K | ﹤0.01% |
+27,200
| New | +$275K |
|
|
PAMT
2527
PAMT CORP Common Stock
PAMT
$258M
| $270K | ﹤0.01% |
13,015
-1,400
| -10% | -$29.1K |
|
2528
Microvast
MVST
$1.06B
| $256K | ﹤0.01% |
182,900
-21,200
| -10% | -$29.7K |
|
2529
NuScale Power
SMR
$4.87B
| $241K | ﹤0.01% |
73,400
+10,800
| +17% | +$35.5K |
|
2530
Marine Products Corp
MPX
$316M
| $233K | ﹤0.01% |
20,400
-2,300
| -10% | -$26.2K |
|
2531
Ventyx Biosciences
VTYX
$164M
| $223K | ﹤0.01% |
90,200
| – | – |
|
2532
Mural Oncology
MURA
$36M
| $195K | ﹤0.01% |
+32,870
| New | +$195K |
|
2533
Aclaris Therapeutics
ACRS
$211M
| $114K | ﹤0.01% |
108,900
| – | – |
|
|
EVA
2534
DELISTED
Enviva Inc.
EVA
| $59.4K | ﹤0.01% |
59,600
| – | – |
|
2535
Future Fuel
FF
$169M
| – | – |
-56,709
| Closed | -$407K |
|
2536
Solid Power
SLDP
$689M
| – | – |
-312,700
| Closed | -$632K |
|
2537
Atlas Energy Solutions
AESI
$1.34B
| – | – |
-37,700
| Closed | -$838K |
|
2538
Aldeyra Therapeutics
ALDX
$324M
| – | – |
-102,000
| Closed | -$681K |
|
|
ALLK
2539
DELISTED
Allakos
ALLK
| – | – |
-93,200
| Closed | -$212K |
|
2540
American Well
AMWL
$107M
| – | – |
-23,160
| Closed | -$542K |
|
2541
Anika Therapeutics
ANIK
$125M
| – | – |
-32,500
| Closed | -$605K |
|
2542
AngioDynamics
ANGO
$433M
| – | – |
-86,300
| Closed | -$631K |
|
2543
Arrow Financial
AROW
$478M
| – | – |
-36,724
| Closed | -$625K |
|
2544
Arcutis Biotherapeutics
ARQT
$2.07B
| – | – |
-101,200
| Closed | -$537K |
|
2545
ATAI Life Sciences
ATAI
$992M
| – | – |
-268,600
| Closed | -$346K |
|
2546
American Vanguard Corp
AVD
$160M
| – | – |
-60,951
| Closed | -$666K |
|
|
JBIO
2547
Jade Biosciences, Inc. Common Stock
JBIO
$251M
| – | – |
-606
| Closed | -$288K |
|
2548
Axogen
AXGN
$755M
| – | – |
-89,689
| Closed | -$448K |
|
2549
Bandwidth Inc
BAND
$495M
| – | – |
-51,900
| Closed | -$585K |
|
2550
Butterfly Network
BFLY
$395M
| – | – |
-331,700
| Closed | -$391K |
|